mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

Health

Mrna Cancer Vaccine Succeeded In Phase 3 Melanoma Trial, Moderna And Merck Say

By Ars Technica

Pharmaceutical partners Moderna and Merck announced on Wednesday that their novel mRNA-based vaccine—individually tailored to target a patient’s unique cancer mutations—was effective in a late-stage clinical trial of patients with melanoma, one of th ...Read more

Related Posts

Major Food Recall Expands To Trader Joe’s, Walmart, Target & More As 345 People Get Sick

Major Food Recall Expands To Trader Joe’s, Walmart, Target & More As 345 People Get Sick

Aug 12, 2026
Lindsay Clancy searched 'can you treat a sociopath' prior to killing children: Investigator

Lindsay Clancy searched 'can you treat a sociopath' prior to killing children: Investigator

Aug 13, 2026
Cyclosporiasis Map 2026, Foods to Avoid as Outbreak Spreads to 47 States

Cyclosporiasis Map 2026, Foods to Avoid as Outbreak Spreads to 47 States

Aug 05, 2026
Florida primaries test Trump's grip on his adopted state

Florida primaries test Trump's grip on his adopted state

Aug 18, 2026
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.